SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $2,527,000 | -58.3% | 33,918 | -3.8% | 0.01% | -60.0% |
Q4 2020 | $6,059,000 | +19.8% | 35,274 | -2.0% | 0.02% | +8.7% |
Q3 2020 | $5,057,000 | -14.5% | 35,996 | -2.4% | 0.02% | -20.7% |
Q2 2020 | $5,915,000 | +61.5% | 36,889 | -1.5% | 0.03% | +38.1% |
Q1 2020 | $3,663,000 | -24.7% | 37,451 | -0.7% | 0.02% | -4.5% |
Q4 2019 | $4,867,000 | +71.3% | 37,714 | 0.0% | 0.02% | +57.1% |
Q3 2019 | $2,841,000 | +3056.7% | 37,714 | +2431.1% | 0.01% | +1300.0% |
Q3 2016 | $90,000 | -81.6% | 1,490 | -85.7% | 0.00% | -85.7% |
Q3 2013 | $490,000 | – | 10,448 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
TOBAM | 371,107 | $27,659,000 | 1.18% |
Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |